What factors influence hospitalizations among dying cancer patients? An analysis of aggressive end-of-life cancer care

<p>Aggressive end-of-life (EOL) care is usually considered to be of poor quality and little value, but cancer patients often make avoidable and distressing hospital visits shortly before death. Cancer patients’ quality of life has been more extensively studied than the quality of dying, which has only recently begun to garner attention in the research community. This exploratory study aimed to identify predictors of aggressive EOL cancer care, with the hope of revealing targets for deeper analysis. The results suggest that racial and ethnic minority status, greater neighborhood poverty, earlier stage at diagnosis, and presence of comorbidity increase the likelihood of receiving aggressive EOL care among dying cancer patients.</p

Elliptic systems with anisotropic potential: existence and regularity of solutions

We briefly summarize existing result in theory of minimizers of elliptic variational functionals. We introduce proof of existence and regularity such functional under assumpti- ons of quaziconvexity and izotrophic growth estimates, and discuss possible generalization to anizotropic case. Our proof is a compilation from more sources, modified in order of simplicity, readability and detailed analysis of all steps

Additional file 5: Table S5. of Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease

Associations of IGF levels and TDLU count among women with benign breast disease with mutual adjustment for IGFBP-3 and IGF-I, overall and stratified by menopausal status. (DOC 44 kb

Additional file 6: Figure S1. of Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease

Association between IGF levels and TDLU count among women with benign breast disease with mutual adjustment for IGFBP-3 and IGF-I, stratified by mammographic density. (DOC 157 kb

Additional file 3: Table S3. of Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease

Associations between IGF levels and median TDLU span among women with benign breast disease, overall and stratified by menopausal status. (DOC 48 kb